5SA-97538-08670
2 vaccinations
1 coded response
10 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 837 / ID
- Registered
- 2021-06-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-25
Dose 1 — Pfizer-BioNTech
-
2021-06-16
Dose 2 — Pfizer-BioNTech
-
2021-06-18
Registered in v-safe
-
2021-06-18
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2021-06-19
- 2021-06-20
- 2021-06-21
- 2021-06-25
- 2021-06-30
- 2021-07-07
- 2021-07-14
-
2021-07-28
Survey response — day 42, dose 2MedDRA: Sinusitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Sinus infectionMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-12-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-25 | Pfizer-BioNTech | |
| 2 | 2021-06-16 | Pfizer-BioNTech |
Free text
Release 9 — day 42, dose 2
Symptoms: Sinus infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Sinusitis | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release